Ms Michelle Gallaher appointed Non-Executive Director
01 Oct 2023
Tan Tock Seng Hospital (Singapore) site visit by CEO 2nd August 2023
August 28, 2023Oculus BioMed Limited partners with The Centre for Eye Research Australia (CERA) in a deal to develop “SwitchGene” – Eye Gene therapies. 11 Oct 2023
October 9, 2023OBM is delighted to welcome Michelle to the Board. She is an exceptional person and professional and brings significant industry experience and skill to the company.
Michelle, is an award-winning medical technology and digital health entrepreneur with a focus in applying artificial intelligence and big data in the development of novel software for the clinical trials industry. With more than 25 years of experience in biotechnology and MedTech, Michelle has led and founded a number of private and publicly listed companies.
As the previous CEO of the ASX-listed biotechnology industry association in Victoria, Australia, Michelle also has extensive experience in government affairs at an international, national and state level.
